PDL Biopharma, Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4477
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PDL Biopharma, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

PDL Biopharma, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PDL Biopharma, Inc., (PDL or ‘the company’), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.

Scope

- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments
- Intelligence on PDL Biopharma, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PDL Biopharma, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
PDL Biopharma, Inc.: Company Overview 9
PDL Biopharma, Inc.: Overview and Key Facts 9
PDL Biopharma, Inc.: Overview 9
PDL Biopharma, Inc.: Key Facts 9
PDL Biopharma, Inc.: Key Employees 11
PDL Biopharma, Inc.: Key Employee Biographies 12
PDL Biopharma, Inc.: Major Products and Services 16
PDL Biopharma, Inc.: Company History 17
PDL Biopharma, Inc.: Management Statement 20
PDL Biopharma, Inc.: Locations and Subsidiaries 21
PDL Biopharma, Inc.: Key Competitors 22
PDL Biopharma, Inc.: Company Analysis 23
PDL Biopharma, Inc.: Business Description 23
PDL Biopharma, Inc.: SWOT Analysis 24
PDL Biopharma, Inc.: SWOT Overview 24
PDL Biopharma, Inc.: Strengths 24
PDL Biopharma, Inc.: Weaknesses 24
PDL Biopharma, Inc.: Opportunities 25
PDL Biopharma, Inc.: Threats 26
PDL Biopharma, Inc.: Corporate Financial Deals Activity 27
PDL Biopharma, Inc.: Financial Deals Overview 27
PDL Biopharma, Inc.: Top Deals 2014 – 2018YTD* 29
PDL Biopharma, Inc.: Mergers and Acquisitions 30
PDL Biopharma, Inc.: Recent Developments 31
PDL Biopharma, Inc.: News and Events Summary 31
PDL Biopharma, Inc.: Business Expansion 33
PDL Biopharma, Inc.: Corporate Governance 34
PDL Biopharma, Inc.: Financial Deals 34
PDL Biopharma, Inc.: Financial Performance 35
PDL Biopharma, Inc.: Red Flags/DistressSignals 36
PDL Biopharma, Inc.: Regulatory and Legal Events 36
PDL Biopharma, Inc.: Strategy and Operations 37
Appendix 38
Contact Us 38
Methodology 38
About MarketLine 39

List of Tables
Table 1: PDL Biopharma, Inc.: Key Facts
Table 2: PDL Biopharma, Inc.: Key Employees
Table 3: PDL Biopharma, Inc.: Locations and Subsidiaries
Table 4: PDL Biopharma, Inc.: Key Competitors
Table 5: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Table 8: PDL Biopharma, Inc.: Top Deals 2014 - 2018YTD*
Table 9: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: PDL Biopharma, Inc.: News and Events Summary
Table 11: PDL Biopharma, Inc.: Business Expansion
Table 12: PDL Biopharma, Inc.: Corporate Governance
Table 13: PDL Biopharma, Inc.: Financial Deals
Table 14: PDL Biopharma, Inc.: Financial Performance
Table 15: PDL Biopharma, Inc.: Red Flags/DistressSignals
Table 16: PDL Biopharma, Inc.: Regulatory and Legal Events
Table 17: PDL Biopharma, Inc.: Strategy and Operations

List of Figures
Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: PDL Biopharma, Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: PDL Biopharma, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[PDL Biopharma, Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Laurus Labs Ltd (LAURUSLABS):製薬・医療:M&Aディール及び事業提携情報
    Summary Laurus Labs Ltd (Laurus Labs) is a drug development company that manufactures active pharmaceutical ingredients. The company develops products through its business divisions such as laurus generics, ingredients and synthesis. It offers active pharmaceutical ingredients and intermediates for …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Pepsi-Cola Products Philippines Inc:戦略・SWOT・企業財務分析
    Pepsi-Cola Products Philippines Inc - Strategy, SWOT and Corporate Finance Report Summary Pepsi-Cola Products Philippines Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • AirStrip Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary AirStrip Technologies Inc (AirStrip) is a healthcare solution provider that offers medical software solutions and services. The company offers mobile interoperability platform interoperability platform that offers access to critical patient data and intelligent insights across the care conti …
  • Singapore Technologies Electronics Ltd:戦略・SWOT・企業財務分析
    Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report Summary Singapore Technologies Electronics Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • China National Petroleum Corp:企業の戦略的SWOT分析
    China National Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • MorphoSys AG (MOR):企業の財務・戦略的SWOT分析
    Summary MorphoSys AG (Morphosys) is a developer of monoclonal antibodies for therapeutic, diagnostic and research applications. The company’s pipeline product includes MOR208, MOR202, MOR103, MOR106, and MOR107. It drugs are used for the treatment of various types of cancers, psoriasis, rheumatoid a …
  • Emerald Expositions, Inc. (EEX):企業の財務・戦略的SWOT分析
    Emerald Expositions, Inc. (EEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Oldenburgische Landesbank AG:企業の戦略・SWOT・財務分析
    Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Oldenburgische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • HDR Inc:企業の戦略的SWOT分析
    HDR Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Cleanaway Waste Management Ltd (CWY):企業の財務・戦略的SWOT分析
    Summary Cleanaway Waste Management Ltd (Cleanaway), formerly Transpacific Industries Group Ltd, is a clean technology company that offers waste management and recycling services. The company's services include general waste cleaning and maintenance, industrial cleaning services, liquid and hazardous …
  • GenKyoTex SA (GKTX):製薬・医療:M&Aディール及び事業提携情報
    Summary GenKyoTex SA (GenKyoTex), formerly Genticel SA, is a biopharmaceutical company that develops NOX therapies. The company develops targeted NOX inhibitors and molecule therapeutics that inhibit the NOX family of enzymes. GenKyoTex’s lead product candidate, GKT831, a selective NOX1/4 inhibitor, …
  • Ana Holdings Inc:企業の戦略・SWOT・財務分析
    Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Ana Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • University of Oslo-製薬・医療分野:企業M&A・提携分析
    Summary University of Oslo (UiO), formerly Birkeland Innovation is an educational service provider that offers research and training services. The university offers bachelor degree program, master’s degree program, PhD program; and research-based education. It offers IT services such as username, pa …
  • Wirtgen GmbH:企業の戦略・SWOT・財務情報
    Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report Summary Wirtgen GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • BNRG Renewables Ltd:電力:M&Aディール及び事業提携情報
    Summary BNRG Renewables Ltd (BNRG) is a renewable energy company that develops, finance and constructs ground mounted and rooftop solar photovoltaic projects. The company offers services such as project management, site assessment, planning and grid connection, asset management, and construction man …
  • Nisshinbo Holdings, Inc.:企業の戦略・SWOT・財務分析
    Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nisshinbo Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Cebu Air Inc:戦略・SWOT・企業財務分析
    Cebu Air Inc - Strategy, SWOT and Corporate Finance Report Summary Cebu Air Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Emerson Electric Co.:戦略・SWOT・企業財務分析
    Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report Summary Emerson Electric Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆